SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Arthur Radley who wrote (158)12/25/2002 9:10:13 PM
From: Jibacoa  Read Replies (1) | Respond to of 3722
 
LGND Is trying to close its November 13 down-gap (Gap Nov.12-Nov.13 (7.14 to 5.75.)Middle of gap= 6.44)

On Dec.3 it traded at 6 and closed at 5.95. On December 10 it traded at 6.24 and closed at 5.97 Yesterday the H was 5.98 and closed ad 5.95

When it can close above 6.44 the next hurdle is 7.05 and then the November 7 H at 7.75 before it can test the more important H of October 3 at 8.15

On its weekly chart the L term average line at present is at 9.57 The volume lately has been light. Last days of heavier volume were on October 20 and October 21 (7.75M & 6.77M respectively)

LGND merits a close watch for a possible start of a near term up-trend on a close above 6.25 for a possible test of its weekly L term average at 9.57(That would be about a 53% gain.<g>)

In Mid-November in Cancer Research (V62 pgs.6376-6380) there was an article from Baylor in which they reported that LGND's bexarotene (Targretin) reduced the development of ER-negative breast tumors in mice.

Last week WellFargo Securities initiated coverage with a Hold rating.<g>

The stock has been selling around 5.2 of book and its cashe/share is now down to less than $0.50. Insiders hold close to 30% and institutions, which have been selling lately, still hold more than 50% of the float.(The short position is around 3.5% of the float)

siliconinvestor.com

It has had a somewhat steep decline Since June this year, so it is possible some of the down-pressure may ease up after the tax-selling is over and if it gets some benefit from the "January Effect.".<g>

siliconinvestor.com

Bernard